Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Guardant Health to Participate in Upcoming Investor Conferences


Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.

Interested parties may access live and archived webcasts of the sessions on the "Investors" section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.


These press releases may also interest you

at 05:45
IFCO appoints Dr. Sebastian Grams as Chief Digital Officer to accelerate Digital Transformation
IFCO, a global leader in reusable packaging solutions, is pleased to announce the appointment of Dr. Sebastian Grams as Chief Digital Officer (CDO). Dr. Grams, a seasoned executive with extensive experience in digitalization and innovation, will lead...

at 05:40
Accenture to Acquire Parsionate, Expanding its Ability to Help Clients Accelerate Data Readiness and Drive Generative AI Adoption
Accenture has agreed to acquire Parsionate, a data consultancy specialized in data products and modern data foundation services, ranging from data strategy development to technology implementation. With deep industry-specific capabilities in the...

at 05:32
Peptide Synthesis: Global Markets Projected to Reach $157.5 Billion by 2028, According to BCC Research Analysis
According to the latest BCC Research study, the demand for Peptide Synthesis: Global Markets is growing from $90.1 billion in 2023 to $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% from 2023 through 2028. The...

at 05:30
Hanwha Launches Engine Leasing Platform
South Korea's 7th largest business enterprise has launched 'Hanwha Aviation', an engine leasing and trading platform with a long-term vertically integrated strategy for newer generation assets.Hanwha will apply extensive experience and expertise in...

at 05:15
Guidehouse Insights Estimates Global Market for Sustainable Manufacturing Will Grow to More Than $150 Billion by 2033
A new report from Guidehouse Insights analyzes major trends in sustainable manufacturing. As climate change accelerates and...

at 05:08
Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the First Quarter of 2024
Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) ("Chunghwa" or "the Company") today reported its un-audited operating results for the first quarter of 2024. All figures were prepared in accordance with Taiwan-International Financial Reporting...

More news about Science and technology...


News published on and distributed by: